BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22483786)

  • 21. Role of 5-HT 2B receptors in cardiomyocyte apoptosis in noradrenaline-induced cardiomyopathy in rats.
    Bai CF; Liu JC; Zhao R; Cao W; Liu SB; Zhang XN; Guo HJ; Yang Q; Yi DH; Zhao MG
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):e145-51. PubMed ID: 20374255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.
    Nikolic K; Agbaba D
    Cardiovasc Ther; 2012 Aug; 30(4):209-16. PubMed ID: 21884004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension.
    Dwyer JP; Ritchie ME; Smyth GK; Harrap SB; Delbridge L; Domenighetti AA; Di Nicolantonio R
    Hypertens Res; 2008 May; 31(5):941-55. PubMed ID: 18712050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats.
    Zhang YL; Geng C; Yang J; Fang J; Yan X; Li PB; Zou LX; Chen C; Guo SB; Li HH; Liu Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165551. PubMed ID: 31494226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
    Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardoguard, an Ayurvedic antihypertensive formulation, prevents cardiac remodeling in spontaneously hypertensive rats by inhibition of ERK and PKCε signaling pathways.
    Sankar V; Nair RR; Harikrishnan VS; Fernandez AC; Kumar CS; Madhavachandran V
    Can J Physiol Pharmacol; 2012 May; 90(5):627-35. PubMed ID: 22550975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
    Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.
    Meijles DN; Cull JJ; Cooper STE; Markou T; Hardyman MA; Fuller SJ; Alharbi HO; Haines ZHR; Alcantara-Alonso V; Glennon PE; Sheppard MN; Sugden PH; Clerk A
    Clin Sci (Lond); 2021 Jul; 135(14):1631-1647. PubMed ID: 34296750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G protein-coupled receptor signalling in in vivo cardiac overload.
    Rapacciuolo A; Esposito G; Prasad SV; Rockman HA
    Acta Physiol Scand; 2001 Sep; 173(1):51-7. PubMed ID: 11678726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease.
    Dukinfield M; Maniati E; Reynolds LE; Aubdool A; Baliga RS; D'Amico G; Maiques O; Wang J; Bedi KC; Margulies KB; Sanz-Moreno V; Hobbs A; Hodivala-Dilke K
    J Pathol; 2019 Dec; 249(4):523-535. PubMed ID: 31424556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat.
    Akinwumi BC; Raj P; Lee DI; Acosta C; Yu L; Thomas SM; Nagabhushanam K; Majeed M; Davies NM; Netticadan T; Anderson HD
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Icariin prevents hypertension-induced cardiomyocyte apoptosis through the mitochondrial apoptotic pathway.
    Qian ZQ; Wang YW; Li YL; Li YQ; Ling-Zhu ; Yang DL
    Biomed Pharmacother; 2017 Apr; 88():823-831. PubMed ID: 28171848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of I
    Keller B; García-Sevilla JA
    Neurochem Int; 2017 Sep; 108():169-176. PubMed ID: 28342965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disturbance of I
    Maltsev AV; Evdokimovskii EV; Kokoz YM
    Arch Biochem Biophys; 2019 Aug; 671():62-68. PubMed ID: 31158332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-bet deficiency attenuates cardiac remodelling in rats.
    Ma ZG; Dai J; Yuan YP; Bian ZY; Xu SC; Jin YG; Zhang X; Tang QZ
    Basic Res Cardiol; 2018 Mar; 113(3):19. PubMed ID: 29564567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin.
    Maziveyi M; Alahari SK
    Cancer Res; 2015 Oct; 75(20):4252-9. PubMed ID: 26392073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.